Your browser doesn't support javascript.
loading
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Wardley, Andrew; Cortes, Javier; Provencher, Louise; Miller, Kathy; Chien, A Jo; Rugo, Hope S; Steinberg, Joyce; Sugg, Jennifer; Tudor, Iulia C; Huizing, Manon; Young, Robyn; Abramson, Vandana; Bose, Ron; Hart, Lowell; Chan, Stephen; Cameron, David; Wright, Gail S; Graas, Marie-Pascale; Neven, Patrick; Rocca, Andrea; Russo, Stefania; Krop, Ian E.
Afiliação
  • Wardley A; NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine, and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Cortes J; Division of Breast Cancers and Gynecological Tumors, IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain.
  • Provencher L; Division of Breast Cancer and Melanoma, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Miller K; Department of Surgery, Centre des Maladies du Sein, CHU de Québec-Université Laval, Québec, Canada.
  • Chien AJ; Indiana University Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, USA.
  • Rugo HS; UCSF Comprehensive Cancer Center, University of California, San Francisco, USA.
  • Steinberg J; UCSF Comprehensive Cancer Center, University of California, San Francisco, USA.
  • Sugg J; Astellas Pharma Inc., Northbrook, USA.
  • Tudor IC; Astellas Pharma Inc., Northbrook, USA.
  • Huizing M; Pfizer Inc., San Francisco, USA.
  • Young R; Department of Oncology, Antwerp University Hospital, Edegem, Belgium.
  • Abramson V; Division of Breast Oncology, The Center for Cancer and Blood Disorders, Fort Worth, USA.
  • Bose R; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA.
  • Hart L; Washington University School of Medicine in St. Louis, Washington University in St. Louis, St. Louis, USA.
  • Chan S; Division of Medical Oncology, Florida Cancer Specialists & Research Institute, Fort Myers, USA.
  • Cameron D; City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Wright GS; University of Edinburgh Cancer Research Centre, IGMM, The University of Edinburgh, Edinburgh, UK.
  • Graas MP; Division of Medical Oncology, Florida Cancer Specialists and Research Institute, New Port Richey, USA.
  • Neven P; Department of Oncology, Le Centre Hospitalier Chrétien (CHC), Liège, Belgium.
  • Rocca A; Department of Gynaecology and Obstetrics, University Hospital Leuven, Leuven, Belgium.
  • Russo S; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Krop IE; Department of Oncology, Udine University Hospital, Udine, Italy.
Breast Cancer Res Treat ; 187(1): 155-165, 2021 May.
Article em En | MEDLINE | ID: mdl-33591468
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article